PTEN and cancer: In agreement with our findings, other studies have exploited DNA-repair-targeted therapies to be selectively synergistic in specific cancer types with PTEN loss, indicating that PTEN loss may represent an actionable vulnerability for the development of more effective treatment strategies [33,34,35].